Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Harry Wilton-Clark"'
Autor:
Harry Wilton-Clark, Toshifumi Yokota
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 30, Iss , Pp 500-501 (2023)
Externí odkaz:
https://doaj.org/article/090d09047714444f8c25549ad0f1e894
Autor:
Harry Wilton-Clark, Toshifumi Yokota
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 778 (2023)
Duchenne muscular dystrophy (DMD) is a debilitating and fatal genetic disease affecting 1/5000 boys globally, characterized by progressive muscle breakdown and eventual death, with an average lifespan in the mid–late twenties. While no cure yet exi
Externí odkaz:
https://doaj.org/article/2a8d80c37c8744e1862b5d6a23699573
Autor:
Kenji Rowel Q. Lim, Md Nur Ahad Shah, Stanley Woo, Harry Wilton-Clark, Pavel Zhabyeyev, Faqi Wang, Rika Maruyama, Gavin Y. Oudit, Toshifumi Yokota
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 23, p 12617 (2021)
Dystrophin is a 427 kDa protein that stabilizes muscle cell membranes through interactions with the cytoskeleton and various membrane-associated proteins. Loss of dystrophin as in Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle w
Externí odkaz:
https://doaj.org/article/96cef2dcc9ff4c008cf4fc45b863e3f8
Autor:
Harry, Wilton-Clark, Toshifumi, Yokota
Publikováno v:
Expert Opinion on Biological Therapy. 23:49-59
Duchenne muscular dystrophy is a lethal genetic disease which currently has no cure, and poor standard treatment options largely focused on symptom relief. The development of multiple biological and genetic therapies is underway across various stages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5f8ee99b6191a7f7e9a3a71ee7f76b
https://doi.org/10.1080/14712598.2022.2150543
https://doi.org/10.1080/14712598.2022.2150543
Autor:
Harry Wilton-Clark, Toshifumi Yokota
Publikováno v:
Genes. 13(2)
Duchenne muscular dystrophy (DMD) is a fatal genetic disease affecting children that is caused by a mutation in the gene encoding for dystrophin. In the absence of functional dystrophin, patients experience progressive muscle deterioration, leaving t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1976719b93904f29cfd9f03a0a543d4
https://pubmed.ncbi.nlm.nih.gov/35205302
https://pubmed.ncbi.nlm.nih.gov/35205302
Autor:
Nur Ahad Shah, Pavel Zhabyeyev, Rika Maruyama, Kenji Rowel Q. Lim, Stanley Woo, Harry Wilton-Clark, Toshifumi Yokota, Faqi Wang, Gavin Y. Oudit
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 12617, p 12617 (2021)
International Journal of Molecular Sciences; Volume 22; Issue 23; Pages: 12617
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 22; Issue 23; Pages: 12617
International Journal of Molecular Sciences
Dystrophin is a 427 kDa protein that stabilizes muscle cell membranes through interactions with the cytoskeleton and various membrane-associated proteins. Loss of dystrophin as in Duchenne muscular dystrophy (DMD) causes progressive skeletal muscle w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb97b6733fdf0bded50e24905611979
https://www.mdpi.com/1422-0067/22/23/12617
https://www.mdpi.com/1422-0067/22/23/12617
Autor:
Lalit Bharadwaj, Alina Kunitskaya, Harry Wilton-Clark, Patricia Lim, Xingyu Chen, Zi Fei Wang, Jacob Grainger, Bilal Sher, Maliyat Noor, Preetha Gopalakrishan, Syeda Ibrahim, Kaitlin Schaaf, Alexandra Ivanova, David Feehan, Michaela Olsakova, Mayi Arcellana-Panlilio, Rachelle Varga
Space exploration has long been a source of inspiration, challenging scientists and engineers to find innovative solutions to various problems. One of the current focuses in space exploration is to send humans to Mars. However, the challenge of trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a7253b150f7a095ff78781eae66f12
https://doi.org/10.1101/288746
https://doi.org/10.1101/288746
